ATE482937T1 - N-phenylacryloylsubstituierte tyrosinderivate als agonisten von hppar-alpha und hppar-gamma - Google Patents

N-phenylacryloylsubstituierte tyrosinderivate als agonisten von hppar-alpha und hppar-gamma

Info

Publication number
ATE482937T1
ATE482937T1 AT05714787T AT05714787T ATE482937T1 AT E482937 T1 ATE482937 T1 AT E482937T1 AT 05714787 T AT05714787 T AT 05714787T AT 05714787 T AT05714787 T AT 05714787T AT E482937 T1 ATE482937 T1 AT E482937T1
Authority
AT
Austria
Prior art keywords
hppar
compound
phenylacryloyl
agonists
gamma
Prior art date
Application number
AT05714787T
Other languages
English (en)
Inventor
Song Li
Xinbo Zhou
Lili Wang
Cheng Xu
Chengmai Ruan
Cuifang Lin
Junhai Xiao
Zhibing Zheng
Hongying Liu
Yunde Xie
Wu Zhong
Hao Cui
Original Assignee
Beijing Molecule Science And T
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Beijing Molecule Science And T filed Critical Beijing Molecule Science And T
Application granted granted Critical
Publication of ATE482937T1 publication Critical patent/ATE482937T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/32—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT05714787T 2004-05-24 2005-03-02 N-phenylacryloylsubstituierte tyrosinderivate als agonisten von hppar-alpha und hppar-gamma ATE482937T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CNB2004100425741A CN100344618C (zh) 2004-05-24 2004-05-24 作为hPPARα和hPPARγ激动剂的N－芳丙烯酰基取代的酪氨酸衍生物
PCT/CN2005/000256 WO2005115999A1 (en) 2004-05-24 2005-03-02 Tyrosine derivatives substituted by n-phenylacryloyl as agonists of hppar alpha and hppar gama

Publications (1)

Publication Number Publication Date
ATE482937T1 true ATE482937T1 (de) 2010-10-15

Family

ID=35450817

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05714787T ATE482937T1 (de) 2004-05-24 2005-03-02 N-phenylacryloylsubstituierte tyrosinderivate als agonisten von hppar-alpha und hppar-gamma

Country Status (7)

Country Link
US (1) US7781468B2 (de)
EP (1) EP1757596B1 (de)
CN (1) CN100344618C (de)
AT (1) ATE482937T1 (de)
DE (1) DE602005023865D1 (de)
ES (1) ES2352071T3 (de)
WO (1) WO2005115999A1 (de)

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5478852C1 (en) * 1993-09-15 2001-03-13 Sankyo Co Use of thiazolidinedione derivatives and related antihyperglycemic agents in the treatment of impaired glucose tolerance in order to prevent or delay the onset of noninsulin-dependent diabetes mellitus
US5478582A (en) * 1994-02-08 1995-12-26 The Quaker Oats Company Dry mixture used for preparing a color-stable liquid composition
GB9817118D0 (en) * 1998-08-07 1998-10-07 Glaxo Group Ltd Pharmaceutical compounds
US6417212B1 (en) * 1999-08-27 2002-07-09 Eli Lilly & Company Modulators of peroxisome proliferator activated receptors
HUP0302306A3 (en) * 2000-10-05 2005-02-28 Bayer Ag Propionic acid derivatives with ppar-alpha activating properties
DE60211891T2 (de) * 2001-05-15 2007-05-24 F. Hoffmann-La Roche Ag Carbonsäure-substituierte oxazol-derivate zur verwendung als ppar-alpha und -gamma aktivatoren zur behandlung von diabetes
HRP20031002A2 (en) * 2001-06-07 2004-06-30 Lilly Co Eli Modulators of peroxisome proliferator activated receptors (ppar)

Also Published As

Publication number Publication date
EP1757596B1 (de) 2010-09-29
CN1702070A (zh) 2005-11-30
CN100344618C (zh) 2007-10-24
US7781468B2 (en) 2010-08-24
EP1757596A4 (de) 2009-01-21
WO2005115999A1 (en) 2005-12-08
US20080300286A1 (en) 2008-12-04
ES2352071T3 (es) 2011-02-15
EP1757596A1 (de) 2007-02-28
DE602005023865D1 (de) 2010-11-11

Similar Documents

Publication Publication Date Title
NO20091596L (no) Benzoylamino-heterocykliske forbindelser som Glucokinase-(GLK)-activatorer
MY142551A (en) Substituted diaryl heterocycles, process for their preparation and their use as medicaments
UY28885A1 (es) 4-fenilamino-quinazolin-6-il-amidas referencia cruzada a solicitud(es) relacionada(s)
NO20076418L (no) Heterocyclic compounds as agonists for the thyroid receptor
TW200621762A (en) Novel compounds
DE60215814D1 (de) Vinylphenyl-derivate als glk-aktivatoren
NO20083036L (no) Anvendelse av benzofuserte heterocykliske sulfamidderivater for behandling av depresjon
BG106825A (en) Substituted oxazolidinones and their use in the field of blood coagulation
NO20084049L (no) Forbindelser med forsterket ampa receptor og anvendelse derav i medisin
ATE269846T1 (de) N-substituierte aminotetraline als neuropeptid y y5 rezeptor-liganden und ihre anwendung zur behandlung von fettleibigkeit und anderen erkrankungen
BRPI0408690A (pt) composto, método para tratamento de uma doença, composição farmacêutica, e, uso de um composto
BRPI0418939A (pt) derivados de nicotinamida e sua utilização como agentes terapêuticos
IL186566A0 (en) Substituted 2-amin0alkylth10-benzimidaz0les and use thereof for reducing blood sugar levels
DE602006019880D1 (de) Verwendung von thienopyridonderivaten als ampk-aktivatoren und pharmazeutische zusammensetzungen, die diese enthalten
NO20083026L (no) Terapeutisk middel for diabetes
BRPI0418099A (pt) compostos, composição farmacêutica, e uso de um composto
EA200601747A1 (ru) Три(цикло)замещённые амидные соединения
CY1112727T1 (el) Παραγωγα κυκλοβουτυλ αμινης βενζοθειαζολης και η χρηση αυτων ως προσδετες των υποδοχεων ισταμινης-3
DE602005019043D1 (de) Glucagonrezeptorantagonisten, deren herstellung und therapeutische verwendung
BRPI0407253A (pt) Heterociclil-3-sulfonilindazóis como ligandos 5-hidroxitriptamina-6 processo de preparação dos mesmos, seus usos na preparação de uma composição farmacêutica e composição farmacêutica compreendendo os referidos compostos
EA200801909A1 (ru) Соединения пиридина для лечения заболеваний, опосредованных действием простагландина
NO20072089L (no) Benzimidazolderivater, sammensetninger som inneholder dem, fremstilling derav og anvendelse derav
AR053082A1 (es) DERIVADOS 8-PERFLUOROALQUIL-6,7,8,9-TETRAHIDROPIRIMIDO[1,2-A]PIRIMIDIN-4-ONA SUBSTITUIDOS NHIBIDORES DE GSK3BETA Y SU EMPLEO EN LA FABRICACIoN DE MEDICAMENTOS PARA EL TRATAMIENTO DE ENFERMEDADES NEURODEGENERATIVAS.
AR043259A1 (es) Metodo para el tratamiento de insuficiencia cardiaca severa y medicamento para ello
JOP20220311A1 (ar) مركبات إنسولين معالجة بأسيل طويلة المفعول

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties